Seidel defends over-the-counter ICS trial
PATIENT self-management will be an increasingly important element of Australian healthcare in future, whether doctors like it or not, a GP says.
Professor Bastian Seidel (pictured), the RACGP’s representative on the National Asthma Council Australia (NAC), responding to comments from Medical Observer readers on a draft proposal to trial OTC supply of inhaled corticosteroids (ICS), says a more pragmatic approach is needed.
“The status quo is not going to cut it. We have avoidable asthma deaths and we need to find ways to